MedTrace Logo

Follow-up of Post-spinal Implantable Neurostimulator PRECISION®

NCT02208999 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 106

Last updated 2019-11-06

Study results available
· View outcomes & findings →

Summary

Assessing the long-term efficacy, complications, revision rates and final explantation of the device

Conditions

  • Chronic Refractory Neuropathic Pain
  • Ischemic Peripheral Pain

Interventions

DEVICE

Neurostimulator Precision

All patients included must have been implanted with the neurostimulator Precision

Sponsors & Collaborators

  • Boston Scientific Corporation

    collaborator INDUSTRY

  • Cemka-Eval

    lead OTHER

Principal Investigators

  • Elisabeth Dr Mouton, MD · Boston Scientific Corporation

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-12-31
Primary Completion
2017-12-31
Completion
2017-12-31

Countries

  • France

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02208999 on ClinicalTrials.gov